HALO logo

Halozyme Therapeutics (HALO) Enterprise value

Enterprise value:

$7.84B-$41.90M(-0.53%)
June 20, 2025

Summary

  • As of today (June 22, 2025), HALO enterprise value is $7.84 billion, with a fall of -$41.90 million (-0.53%) during the most recent trading session on June 20, 2025.
  • Over the past year, HALO enterprise value has dropped by -$42.26 million (-0.54%).
  • HALO enterprise value is now -21.41% below its all-time high of $9.97 billion.

Performance

HALO Enterprise value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherHALOvaluation metrics

Enterprise value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

HALO Enterprise value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-0.5%-0.6%-0.6%
1 m1 month-1.0%-1.2%-1.2%
3 m3 months-15.5%-18.1%-17.9%
6 m6 months+7.5%+9.5%+12.5%
ytdytd-+9.8%+10.5%
1 y1 year-0.5%-0.6%+3.8%
5 y5 years+117.5%+96.0%+116.1%

HALO Enterprise value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month$8.24B-4.9%$7.84Bat low
3 m3-month$9.97B-21.4%$7.23B+8.3%
6 m6-month$9.97B-21.4%$7.23B+8.3%
1 y1-year$9.97B-21.4%$6.21B+26.3%
3 y3-year$9.97B-21.4%$5.39B+45.5%
5 y5-year$9.97B-21.4%$3.60B+117.5%
alltimeall time$9.97B-21.4%$50.57M>+9999.0%

HALO Enterprise value History

DateValue
2025
$7.84B(+29.2%)
2023
$6.07B(-32.2%)
2022
$8.95B(+42.3%)
2021
$6.29B(+4.5%)
2020
$6.02B(+122.3%)
2019
$2.71B(+23.8%)
2018
$2.19B(-25.3%)
2017
$2.93B(+104.7%)
2016
$1.43B(-35.8%)
2015
$2.23B(+85.4%)
DateValue
2014
$1.20B(-30.9%)
2013
$1.74B(+152.8%)
2012
$687.89M(-26.5%)
2011
$936.11M(+31.2%)
2010
$713.34M(+51.5%)
2009
$470.71M(+20.0%)
2008
$392.37M(-14.0%)
2007
$456.22M(-10.4%)
2006
$509.14M(+462.5%)
2005
$90.52M(-1.9%)
2004
$92.24M

FAQ

  • What is Halozyme Therapeutics enterprise value?
  • What is the all time high enterprise value for Halozyme Therapeutics?
  • What is Halozyme Therapeutics enterprise value year-on-year change?

What is Halozyme Therapeutics enterprise value?

The current enterprise value of HALO is $7.84B

What is the all time high enterprise value for Halozyme Therapeutics?

Halozyme Therapeutics all-time high enterprise value is $9.97B

What is Halozyme Therapeutics enterprise value year-on-year change?

Over the past year, HALO enterprise value has changed by -$42.26M (-0.54%)
On this page